Page last updated: 2024-08-25

chitosan and Helicobacter Infections

chitosan has been researched along with Helicobacter Infections in 37 studies

Research

Studies (37)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (2.70)	18.2507
2000's	15 (40.54)	29.6817
2010's	16 (43.24)	24.3611
2020's	5 (13.51)	2.80

Authors

Authors	Studies
Estevinho, BN; Fonseca, DR; Gomes, P; Henriques, PC; Leiro, V; Lucena, M; Martins, MCL; Moura, A; Parreira, P; Seabra, CL; Silva-Carvalho, R; Teixeira, C	1
Abdalla, M; Ahmad, R; Arif, M; Eltayb, WA; Liu, CG; Muhammad, J; Sharaf, M	1
Li, W; Wang, X; Xiao, S; Zhang, L	1
Chehelgerdi, M; Doosti, A	1
Antunes, B; Costa, LM; Costa, P; Gartner, F; Gomes, J; Gonçalves, IC; Henriques, PC; Junqueira-Neto, S; Magalhães, A; Maia, AF; Martins, MCL; Oliveira, P; Reis, CA; Seabra, CL; Silva-Carvalho, R; Touati, E	1
Jia, YY; Jing, ZW; Li, C; Luo, M; Mei, QB; Zhang, BL; Zhou, SY	1
Lima, SAC; Lopes-de-Campos, D; Nunes, C; Pinto, RM; Reis, S; Santos, T; Sarmento, B	1
He, ZS; Lai, CH; Lee, CH; Lin, YH; Tsai, SC; Tseng, GC	1
Fernandes, M; Gonçalves, IC; Magalhães, A; Martins, MC; Reis, CA; Rodrigues, IV	1
Adebisi, AO; Conway, BR	1
Gide, PS; Thombre, NA	1
Gonçalves, IC; Henriques, PC; Martins, MC; Seabra, CL	1
Chang, CH; Chang, SJ; Chen, YS; Chou, SC; Chung, CC; Lin, JH; Lin, YH	1
Guo, L; Li, X; Liu, W; Lv, X; Xi, T; Xing, Y	1
Gong, Y; Hu, S; Jing, L; Liu, D; Liu, W; Tao, L; Wang, F; Xie, Y; Zhou, N	1
Aboul-Einien, MH; El-Mahrouk, GM; Makhlouf, AI	1
De, A; De, PK; De, R; Dey, SK; Mukhopadhyay, AK; Ojha, S; Samanta, A	1
Bhattacharya, S; Ganesh, N; Jain, NK; Ramteke, S	1
Chang, CH; Chen, YJ; Chiou, SF; Hsu, YM; Lin, YH; Wu, YS	1
Kim, D; Park, J	1
Chang, M; Cheng, X; Guo, J; Li, G; Luo, D; Sun, J; Wang, F; Yan, X	1
Chang, CH; Chen, YC; Chen, YS; Chiou, SF; Hsu, YM; Lin, YH; Wang, CC; Yeh, CL	1
Muangsin, N; Praphairaksit, N; Sahasathian, T	1
Davaran, S; Jasoori, S; Moogooee, M; Omidi, Y; Ramezanzadeh, H	1
Patel, J; Patil, P	1
de la Torre, PM; Enobakhare, Y; Torrado, G; Torrado, S	1
Amiji, M; Hejazi, R	3
de la Torre, PM; Torrado, G; Torrado, S	1
Alpar, HO; Bramwell, VW; Moschos, SA; Somavarapu, S	1
Chen, J; Gong, YF; Lü, NH; Wang, CW; Xie, Y; Zhou, NJ; Zhou, XJ	1
Gisbert, JP; Olivares, D; Pajares, JM; Torrado, G; Torrado, S	1
Patel, JK; Patel, MM	1
Chen, J; Gong, YF; Hou, XH; Hu, SJ; Lu, NH; Xie, Y; Zhou, NJ; Zhou, XJ	1
Chen, J; Gong, YF; Lü, NH; Wang, CW; Xie, Y; Xiong, SY; Zhou, NJ	1
Amiji, M; Patel, V; Qaqish, R; Shah, S	1

Reviews

1 review(s) available for chitosan and Helicobacter Infections

Article	Year
The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection. Expert review of anti-infective therapy, 2014, Volume: 12, Issue:8 Topics: Adhesiveness; Anti-Bacterial Agents; Chitosan; Drug Carriers; Drug Compounding; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Nanoparticles; Peptic Ulcer; Stomach Neoplasms	2014

Other Studies

36 other study(ies) available for chitosan and Helicobacter Infections

Article	Year
Grafting MSI-78A onto chitosan microspheres enhances its antimicrobial activity. Acta biomaterialia, 2022, 01-01, Volume: 137 Topics: Anti-Bacterial Agents; Antimicrobial Peptides; Chitosan; Helicobacter Infections; Helicobacter pylori; Humans; Microspheres	2022
Antibacterial and antibiofilm activity of mannose-modified chitosan/PMLA nanoparticles against multidrug-resistant Helicobacter pylori. International journal of biological macromolecules, 2022, Dec-31, Volume: 223, Issue:Pt A Topics: Anti-Bacterial Agents; Chitosan; Helicobacter Infections; Helicobacter pylori; Humans; Mannose; Molecular Docking Simulation; Nanoparticles	2022
The signal conversion strategy using the lytic transglycosylase Cag4-double nanoporous gold co-catalysis for the rapid screening of drugs against Helicobacter pylori infection. Biosensors & bioelectronics, 2023, Aug-01, Volume: 233 Topics: Antigens, Bacterial; Bacterial Proteins; Biosensing Techniques; Chitosan; Escherichia coli; Helicobacter Infections; Helicobacter pylori; Humans; Molecular Docking Simulation; Nanopores	2023
Effect of the cagW-based gene vaccine on the immunologic properties of BALB/c mouse: an efficient candidate for Helicobacter pylori DNA vaccine. Journal of nanobiotechnology, 2020, Apr-21, Volume: 18, Issue:1 Topics: Animals; Antibodies, Bacterial; Bacterial Proteins; CD8-Positive T-Lymphocytes; Chitosan; Disease Models, Animal; Helicobacter Infections; Helicobacter pylori; Immunity, Cellular; Interferon-gamma; Mice; Mice, Inbred BALB C; Nanoparticles; Plasmids; Transfection; Vaccines, DNA; Virulence Factors	2020
Orally administrated chitosan microspheres bind Helicobacter pylori and decrease gastric infection in mice. Acta biomaterialia, 2020, 09-15, Volume: 114 Topics: Animals; Chitosan; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Mice; Mice, Inbred C57BL; Microspheres	2020
Anti-Helicobacterpylori effectiveness and targeted delivery performance of amoxicillin-UCCs-2/TPP nanoparticles based on ureido-modified chitosan derivative. International journal of biological macromolecules, 2018, Volume: 115 Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Biological Transport; Chitosan; Cytokines; Drug Carriers; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Polyphosphates; Stomach; Structure-Activity Relationship; Urea	2018
Delivering amoxicillin at the infection site - a rational design through lipid nanoparticles. International journal of nanomedicine, 2019, Volume: 14 Topics: Amoxicillin; Animals; Cell Line; Cell Membrane Permeability; Cell Survival; Chitosan; Drug Carriers; Drug Liberation; Helicobacter Infections; Helicobacter pylori; Humans; Lipids; Mice; Mucins; Nanoparticles; Particle Size	2019
Genipin-cross-linked fucose-chitosan/heparin nanoparticles for the eradication of Helicobacter pylori. Biomaterials, 2013, Volume: 34, Issue:18 Topics: Amoxicillin; Animals; Cell Line; Cell Survival; Chitosan; Coculture Techniques; Cross-Linking Reagents; Fluorescent Antibody Technique; Fucose; Helicobacter Infections; Helicobacter pylori; Heparin; Humans; Hydrogen-Ion Concentration; Iridoids; Male; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Spectroscopy, Fourier Transform Infrared; Static Electricity	2013
Bacterial-binding chitosan microspheres for gastric infection treatment and prevention. Acta biomaterialia, 2013, Volume: 9, Issue:12 Topics: Adhesins, Bacterial; Animals; Bacterial Adhesion; Cell Line, Tumor; Cell Survival; Chitosan; Cross-Linking Reagents; Fluorescein-5-isothiocyanate; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Iridoids; Microscopy, Electron, Scanning; Microspheres; Particle Size	2013
Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus. International journal of pharmaceutics, 2014, Aug-15, Volume: 470, Issue:1-2 Topics: Adhesiveness; Animals; Anti-Bacterial Agents; Cellulose; Chitosan; Clarithromycin; Concanavalin A; Diffusion; Drug Stability; Gastric Juice; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Membranes, Artificial; Microspheres; Mucins; Mucus; Powder Diffraction; Spectroscopy, Fourier Transform Infrared; Swine; X-Ray Diffraction	2014
Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication. Drug delivery, 2016, Volume: 23, Issue:2 Topics: Adhesiveness; Administration, Oral; Alginates; Amoxicillin; Animals; Anti-Bacterial Agents; Biological Availability; Caesalpinia; Calorimetry, Differential Scanning; Chitosan; Crystallography, X-Ray; Delayed-Action Preparations; Disease Models, Animal; Dosage Forms; Drug Carriers; Drug Compounding; Female; Galactose; Gastric Mucosa; Glucuronic Acid; Helicobacter Infections; Helicobacter pylori; Hexuronic Acids; Kinetics; Male; Mannans; Models, Chemical; Particle Size; Powder Diffraction; Rats, Wistar; Solubility; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical	2016
Berberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study. Nanomedicine (London, England), 2015, Volume: 10, Issue:1 Topics: Animals; Berberine; Chitosan; Drug Delivery Systems; Fucose; Helicobacter Infections; Helicobacter pylori; Heparin; Humans; Mice; Microscopy, Confocal; Nanoparticles	2015
Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori. Biochemical and biophysical research communications, 2015, Jul-03, Volume: 462, Issue:3 Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Antibodies, Bacterial; Antibody Specificity; Bacterial Vaccines; Chitosan; Cholera Toxin; CpG Islands; Cytokines; Epitopes; Helicobacter Infections; Helicobacter pylori; Immunity, Mucosal; Immunoglobulin A, Secretory; Male; Mice; Mice, Inbred BALB C; Urease; Vaccines, Synthetic	2015
Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine. Molecular medicine reports, 2015, Volume: 12, Issue:3 Topics: Adjuvants, Immunologic; Animals; Antibodies, Bacterial; Bacterial Proteins; Bacterial Vaccines; Chitosan; Cholera Toxin; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Forkhead Transcription Factors; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Immunohistochemistry; Mice; Mice, Inbred BALB C; Saliva; T-Lymphocytes, Regulatory; Th1 Cells; Th2 Cells; Toll-Like Receptor 4	2015
Design, Optimization, and Evaluation of a Novel Metronidazole-Loaded Gastro-Retentive pH-Sensitive Hydrogel. AAPS PharmSciTech, 2016, Volume: 17, Issue:6 Topics: Animals; Chemistry, Pharmaceutical; Chitosan; Dogs; Drug Carriers; Drug Delivery Systems; Drug Liberation; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogen-Ion Concentration; Metronidazole; Polyphosphates	2016
Floating mucoadhesive alginate beads of amoxicillin trihydrate: A facile approach for H. pylori eradication. International journal of biological macromolecules, 2016, Volume: 89 Topics: Alginates; Amoxicillin; Animals; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Gastric Mucosa; Glucuronic Acid; Helicobacter Infections; Helicobacter pylori; Hexuronic Acids; Humans; Hypromellose Derivatives; Plant Oils; Rabbits; Stomach; Sunflower Oil	2016
Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori. Journal of drug targeting, 2009, Volume: 17, Issue:3 Topics: Amoxicillin; Animals; Cells, Cultured; Chitosan; Clarithromycin; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Stability; Female; Glutamic Acid; Helicobacter Infections; Helicobacter pylori; Male; Mice; Nanoparticles; Omeprazole; Random Allocation	2009
Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy. Biomaterials, 2009, Volume: 30, Issue:19 Topics: Animals; Biocompatible Materials; Cells, Cultured; Chitosan; Coculture Techniques; Fluorescent Dyes; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Heparin; Humans; Hydrogen-Ion Concentration; Male; Materials Testing; Mice; Mice, Inbred BALB C; Molecular Structure; Nanoparticles	2009
Release behavior of amoxicillin from glycol chitosan superporous hydrogels. Journal of biomaterials science. Polymer edition, 2009, Volume: 20, Issue:5-6 Topics: Amoxicillin; Anti-Bacterial Agents; Biocompatible Materials; Chitosan; Drug Carriers; Drug Delivery Systems; Glycols; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogels; In Vitro Techniques; Materials Testing; Microscopy, Electron, Scanning	2009
Preparation and evaluation of anti-Helicobacter pylori efficacy of chitosan nanoparticles in vitro and in vivo. Journal of biomaterials science. Polymer edition, 2009, Volume: 20, Issue:11 Topics: Animals; Chitosan; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Mice; Mice, Inbred BALB C; Nanoparticles	2009
Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori. Biomacromolecules, 2010, Jan-11, Volume: 11, Issue:1 Topics: Adenocarcinoma; Amoxicillin; Animals; Anti-Bacterial Agents; Chitosan; Drug Carriers; Drug Delivery Systems; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Hydrogels; Hydrogen-Ion Concentration; Nanoparticles; Stomach Neoplasms; Tumor Cells, Cultured	2010
Mucoadhesive and floating chitosan-coated alginate beads for the controlled gastric release of amoxicillin. Archives of pharmacal research, 2010, Volume: 33, Issue:6 Topics: Adhesiveness; Alginates; Amoxicillin; Anti-Bacterial Agents; Chemical Phenomena; Chitosan; Delayed-Action Preparations; Diffusion; Drug Compounding; Drug Delivery Systems; Gastric Mucosa; Gastrointestinal Transit; Gelatin; Glucuronic Acid; Helicobacter Infections; Helicobacter pylori; Hexuronic Acids; Intestinal Secretions; Kinetics; Microspheres; Peptic Ulcer; Pharmaceutical Vehicles; Surface Properties	2010
Synthesis and in vitro studies of cross-linked hydrogel nanoparticles containing amoxicillin. Journal of pharmaceutical sciences, 2011, Volume: 100, Issue:3 Topics: Acrylamides; Amoxicillin; Animals; Anti-Bacterial Agents; Chitosan; Drug Carriers; Drug Delivery Systems; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogels; Methacrylates; Nanoparticles; Particle Size; Polymers; Rats; Rats, Sprague-Dawley; Solubility; Stomach; Transition Temperature	2011
Preparation and characterization of amoxicillin mucoadhesive microparticles using solution-enhanced dispersion by supercritical CO₂. Journal of microencapsulation, 2012, Volume: 29, Issue:4 Topics: Adhesiveness; Amoxicillin; Animals; Anti-Bacterial Agents; Calorimetry, Differential Scanning; Carbon Dioxide; Chitosan; Drug Compounding; Duodenal Ulcer; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Male; Microscopy, Electron, Scanning; Particle Size; Powder Diffraction; Rats; Rats, Wistar; Solutions; Stomach Ulcer	2012
Release of amoxicillin from polyionic complexes of chitosan and poly(acrylic acid). Study of polymer/polymer and polymer/drug interactions within the network structure. Biomaterials, 2003, Volume: 24, Issue:8 Topics: Acrylic Resins; Amoxicillin; Biocompatible Materials; Chitin; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogels; In Vitro Techniques; Ions; Materials Testing; Microscopy, Electron, Scanning; Penicillins; Spectroscopy, Fourier Transform Infrared	2003
Stomach-specific anti-H. pylori therapy. II. Gastric residence studies of tetracycline-loaded chitosan microspheres in gerbils. Pharmaceutical development and technology, 2003, Volume: 8, Issue:3 Topics: Animals; Chitin; Chitosan; Delayed-Action Preparations; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Microspheres; Stomach; Tetracycline	2003
Stomach-specific anti-H. pylori therapy; part III: effect of chitosan microspheres crosslinking on the gastric residence and local tetracycline concentrations in fasted gerbils. International journal of pharmaceutics, 2004, Mar-19, Volume: 272, Issue:1-2 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Chitin; Chitosan; Cross-Linking Reagents; Fasting; Gastric Mucosa; Gerbillinae; Glyoxal; Helicobacter Infections; Helicobacter pylori; Male; Microspheres; Surface Properties; Tetracycline	2004
Poly (acrylic acid) chitosan interpolymer complexes for stomach controlled antibiotic delivery. Journal of biomedical materials research. Part B, Applied biomaterials, 2005, Jan-15, Volume: 72, Issue:1 Topics: Acrylic Resins; Adult; Amoxicillin; Chitosan; Drug Delivery Systems; Female; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Kinetics; Male; Microscopy, Electron, Scanning; Organ Specificity; Stomach	2005
Comparative immunomodulatory properties of a chitosan-MDP adjuvant combination following intranasal or intramuscular immunisation. Vaccine, 2005, Mar-14, Volume: 23, Issue:16 Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Administration, Intranasal; Animals; Antigens, Bacterial; Cell Proliferation; Cells, Cultured; Chitosan; Feces; Female; Helicobacter Infections; Helicobacter pylori; Immunization; Immunization Schedule; Immunoglobulin G; Injections, Intramuscular; Mice; Mice, Inbred BALB C; Spleen; Urease	2005
[The role of local immune response in gastric mucosa in the protection induced by Helicobacter pylori vaccine with chitosan as adjuvant]. Zhonghua yi xue za zhi, 2005, Sep-28, Volume: 85, Issue:37 Topics: Adjuvants, Immunologic; Animals; Bacterial Vaccines; Chitosan; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Mice; Mice, Inbred BALB C	2005
Clinical trial evaluating amoxicillin and clarithromycin hydrogels (Chitosan-polyacrylic acid polyionic complex) for H. pylori eradication. Journal of clinical gastroenterology, 2006, Volume: 40, Issue:7 Topics: Acrylic Resins; Adult; Amoxicillin; Anti-Bacterial Agents; Biocompatible Materials; Chitosan; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogels; Male; Middle Aged	2006
Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres. Current drug delivery, 2007, Volume: 4, Issue:1 Topics: Acetic Acid; Adhesiveness; Amoxicillin; Animals; Anti-Bacterial Agents; Biological Availability; Chitosan; Dioctyl Sulfosuccinic Acid; Drug Delivery Systems; Glutaral; Helicobacter Infections; Helicobacter pylori; Microscopy, Electron, Scanning; Microspheres; Mineral Oil; Particle Size; Powders; Rats; Reproducibility of Results; Stomach	2007
Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection. World journal of gastroenterology, 2007, Mar-14, Volume: 13, Issue:10 Topics: Adjuvants, Immunologic; Animals; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Vaccines; Chitosan; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Immunoglobulin G; Interleukin-10; Interleukin-4; Mice; Mice, Inbred BALB C; Random Allocation; Th1 Cells; Th2 Cells	2007
[Anti-Helicobacter pylori effect and regulation of T helper response of chitosan]. Zhonghua nei ke za zhi, 2007, Volume: 46, Issue:3 Topics: Animals; Chitosan; Enzyme-Linked Immunosorbent Assay; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Interleukin-10; Interleukin-12; Interleukin-4; Mice; Mice, Inbred BALB C	2007
Evaluation of the factors influencing stomach-specific delivery of antibacterial agents for Helicobacter pylori infection. The Journal of pharmacy and pharmacology, 1999, Volume: 51, Issue:6 Topics: Amoxicillin; Chitin; Chitosan; Drug Stability; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Metronidazole; Microspheres; Permeability	1999
Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan microspheres. International journal of pharmaceutics, 2002, Mar-20, Volume: 235, Issue:1-2 Topics: Anti-Bacterial Agents; Biocompatible Materials; Chemistry, Pharmaceutical; Chitin; Chitosan; Drug Evaluation, Preclinical; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Microspheres; Particle Size; Stomach; Technology, Pharmaceutical; Tetracycline	2002